Clinical and Technical Characteristics of Coronary Angiography and Percutaneous Coronary Interventions Performed before and after Transcatheter Aortic Valve Replacement with a Balloon-Expandable Valve
暂无分享,去创建一个
R. Puri | J. Rodés‐Cabau | E. Dumont | J. Paradis | R. Delarochelliére | L. Guimarães | S. Mohammadi | A. Ferreira-Neto | L. Asmarats | Victoria Vilalta | V. Vilalta
[1] J. Rodés‐Cabau,et al. Coronary Artery Disease and Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.
[2] F. Maes,et al. Incidence, Clinical Characteristics, and Impact of Acute Coronary Syndrome Following Transcatheter Aortic Valve Replacement. , 2018, JACC. Cardiovascular interventions.
[3] C. Grines,et al. Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic™ self‐expandable bioprosthetic valve , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[4] Samin K. Sharma,et al. Coronary Angiography and Percutaneous Coronary Intervention After Transcatheter Aortic Valve Replacement. , 2018, Journal of the American College of Cardiology.
[5] Tania Rodríguez-Gabella,et al. Latest-Generation Transcatheter Aortic Valve Replacement Devices and Procedures. , 2017, The Canadian journal of cardiology.
[6] L. Fleisher,et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.
[7] J. Townend,et al. Transcatheter Aortic Valve Implantation With or Without Percutaneous Coronary Artery Revascularization Strategy: A Systematic Review and Meta‐Analysis , 2017, Journal of the American Heart Association.
[8] Andrew S. Mugglin,et al. Surgical or Transcatheter Aortic‐Valve Replacement in Intermediate‐Risk Patients , 2017, The New England journal of medicine.
[9] Thomas M Maddox,et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, , 2017, Journal of the American College of Cardiology.
[10] D. Muir,et al. Management strategies for severe aortic stenosis and coronary artery disease in the transcatheter aortic valve implantation era , 2017 .
[11] J. Dubois-Randé,et al. Coronary Procedures After TAVI With the Self‐Expanding Aortic Bioprosthesis Medtronic CoreValve™, Not an Easy Matter , 2017, Journal of interventional cardiology.
[12] G. Richardt,et al. Incidence, feasibility and outcome of percutaneous coronary intervention after transcatheter aortic valve implantation with a self-expanding prosthesis. Results from a single center experience. , 2016, Cardiovascular revascularization medicine : including molecular interventions.
[13] R. Makkar,et al. Aortic Angulation Attenuates Procedural Success Following Self-Expandable But Not Balloon-Expandable TAVR. , 2016, JACC. Cardiovascular imaging.
[14] B. Iung,et al. TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation. , 2016, European heart journal.
[15] M. Mack,et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.
[16] L. W. Andersen,et al. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. , 2015, Journal of the American College of Cardiology.
[17] T. Walther,et al. Challenges of coronary angiography and intervention in patients previously treated by TAVI , 2015, Clinical Research in Cardiology.
[18] Jeroen J. Bax,et al. Position of Edwards SAPIEN transcatheter valve in the aortic root in relation with the coronary ostia , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[19] Helmut Baumgartner,et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[20] K. Harjai,et al. Aortic stenosis and coronary artery disease: what do we know? What don't we know? A comprehensive review of the literature with proposed treatment algorithms. , 2014, European heart journal.
[21] Maurice Buchbinder,et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. , 2014, The New England journal of medicine.
[22] Y. Arbel,et al. Comparison of early and late outcomes of TAVI alone compared to TAVI plus PCI in aortic stenosis patients with and without coronary artery disease , 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[23] A. Bankier,et al. Imaging in Transcatheter Aortic Valve Replacement (TAVR): role of the radiologist , 2014, Insights into Imaging.
[24] Stuart J Pocock,et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.
[25] B. Carabello. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery , 2011, Current cardiology reports.
[26] S. Pocock,et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.
[27] Tania Rodríguez-Gabella,et al. Future of transcatheter aortic valve implantation — evolving clinical indications , 2018, Nature Reviews Cardiology.
[28] L. Fleisher,et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Circulation.
[29] Volkmar Falk,et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Ca , 2014, European heart journal.
[30] Helmut Baumgartner,et al. ESC / EACTS Guidelines on myocardial revascularization , 2014 .